How Do You Feel Today? v4
Moderators: Orlion, balon!, aliantha
- Menolly
- A Lowly Harper
- Posts: 24111
- Joined: Thu May 19, 2005 12:29 am
- Location: Harper Hall, Fort Hold, Northern Continent, Pern...
- Has thanked: 1 time
- Been thanked: 9 times
- Contact:
Oh...
So that's why I'm having a second dose of Evushield tomorrow. They increased the initial dose a week after my treatment. I didn't recall being told it was a two dose treatment initially.
From Seattle Cancer Care Alliance:
Evusheld
While vaccines play a critical role in keeping you safe, we recognize that some of you may not have a strong response to COVID-19 vaccination. If you meet the eligibility requirements listed below and supply is available, you may be able to receive Evusheld (tixagevimab and cilgavimab), a medication used to prevent COVID-19 infection before you are exposed to the virus.
Evusheld is not used to treat COVID-19 infection or for people with known exposure to COVID-19. Evusheld is not a replacement for COVID-19 vaccination. If you can safely get the COVID-19 vaccine and have not already, we encourage you to do so. If you are not sure if the vaccine is safe for you, please ask your care team.
Who is eligible for Evusheld?
Currently, there is a limited supply of Evusheld available. We are prioritizing our most immunocompromised patients based on National Institutes of Health guidelines, which include:
Active pre-transplant/HCT within one year, those with chronic GVHD or who are taking immunosuppressive medications for another indication.
CAR T cell recipients
Hematologic malignancy patients on active therapy
Patients who are within 1 year of receiving B-cell depleting therapies
Patients receiving Bruton tyrosine kinase inhibitors
Patients with severe combined immunodeficiencies
Lung transplant recipients
Patients who are within 1 year of receiving a solid-organ transplant (other than lung transplant)
Solid-organ transplant recipients with recent treatment for acute rejection with T or B cell depleting agents
Patients with untreated HIV who have a CD4 T lymphocyte cell count <50 cells/mm³
If you are eligible to receive Evusheld, your care team will discuss this with you at an upcoming appointment. If, after your conversation with your care team, you decide you want to take Evusheld, you’ll be added to a waitlist and contacted when it is your turn. We will re-evaluate eligibility criteria as supply allows and will keep you updated when more patients become eligible for this treatment.
Recent changes to Evusheld dose
On February 24, the U.S. Food and Drug Administration (FDA) revised the emergency use authorization (EUA) for Evusheld to increase the initial dose.
The dose was revised based on information that shows a higher dose of Evusheld may be more likely to prevent infection by the COVID-19 Omicron subvariants.
If you already received an initial dose of Evusheld:
Your care team will contact you in the coming weeks, if they have not already done so, to schedule a second dose.
If you decline a second dose when it’s offered to you and later change your mind, you may contact your care team at any time and tell them you would like to be scheduled.
So that's why I'm having a second dose of Evushield tomorrow. They increased the initial dose a week after my treatment. I didn't recall being told it was a two dose treatment initially.
From Seattle Cancer Care Alliance:
Evusheld
While vaccines play a critical role in keeping you safe, we recognize that some of you may not have a strong response to COVID-19 vaccination. If you meet the eligibility requirements listed below and supply is available, you may be able to receive Evusheld (tixagevimab and cilgavimab), a medication used to prevent COVID-19 infection before you are exposed to the virus.
Evusheld is not used to treat COVID-19 infection or for people with known exposure to COVID-19. Evusheld is not a replacement for COVID-19 vaccination. If you can safely get the COVID-19 vaccine and have not already, we encourage you to do so. If you are not sure if the vaccine is safe for you, please ask your care team.
Who is eligible for Evusheld?
Currently, there is a limited supply of Evusheld available. We are prioritizing our most immunocompromised patients based on National Institutes of Health guidelines, which include:
Active pre-transplant/HCT within one year, those with chronic GVHD or who are taking immunosuppressive medications for another indication.
CAR T cell recipients
Hematologic malignancy patients on active therapy
Patients who are within 1 year of receiving B-cell depleting therapies
Patients receiving Bruton tyrosine kinase inhibitors
Patients with severe combined immunodeficiencies
Lung transplant recipients
Patients who are within 1 year of receiving a solid-organ transplant (other than lung transplant)
Solid-organ transplant recipients with recent treatment for acute rejection with T or B cell depleting agents
Patients with untreated HIV who have a CD4 T lymphocyte cell count <50 cells/mm³
If you are eligible to receive Evusheld, your care team will discuss this with you at an upcoming appointment. If, after your conversation with your care team, you decide you want to take Evusheld, you’ll be added to a waitlist and contacted when it is your turn. We will re-evaluate eligibility criteria as supply allows and will keep you updated when more patients become eligible for this treatment.
Recent changes to Evusheld dose
On February 24, the U.S. Food and Drug Administration (FDA) revised the emergency use authorization (EUA) for Evusheld to increase the initial dose.
The dose was revised based on information that shows a higher dose of Evusheld may be more likely to prevent infection by the COVID-19 Omicron subvariants.
If you already received an initial dose of Evusheld:
Your care team will contact you in the coming weeks, if they have not already done so, to schedule a second dose.
If you decline a second dose when it’s offered to you and later change your mind, you may contact your care team at any time and tell them you would like to be scheduled.
- Khaliban
- Watchman, Second Class
- Posts: 2934
- Joined: Sun Feb 22, 2004 5:55 am
- Location: Evanston, IL
- Contact:
I think the rabbit is probably dead. Or hiding. Or in hibernation. I'm betting the last one. It might be another year before it pokes it's nose out.
"This is the sort of bloody nonsense up with which I will not put."
Smashwords: Discovered Mate: A Tale of Desire and Chess
Some Stories: FanFiction or Archive Of Our Own
Smashwords: Discovered Mate: A Tale of Desire and Chess
Some Stories: FanFiction or Archive Of Our Own
- Savor Dam
- Will Be Herd!
- Posts: 6178
- Joined: Mon Mar 02, 2009 7:02 am
- Location: Pacific NorthWet
- Has thanked: 3 times
- Been thanked: 7 times
Rabbit is neither dead, nor hiding, nor hibernating. Two were cavorting on the deck today, one of whom came right up to the sliding glass door before skittering away when it realized I saw it.
Love prevails.
~ Tracie Mckinney-Hammon
Change is not a process for the impatient.
~ Barbara Reinhold
A government which robs Peter to pay Paul, can always count on the support of Paul.
~ George Bernard Shaw
~ Tracie Mckinney-Hammon
Change is not a process for the impatient.
~ Barbara Reinhold
A government which robs Peter to pay Paul, can always count on the support of Paul.
~ George Bernard Shaw
- Avatar
- Immanentizing The Eschaton
- Posts: 61942
- Joined: Mon Aug 02, 2004 9:17 am
- Location: Johannesburg, South Africa
- Has thanked: 18 times
- Been thanked: 28 times
Sheesh, I took a week off for my birthday, and nothing happened? Well, nothing here anyway.
Apart from my birthday, I also had some idiot drive into me, (nothing serious, just cosmetic damage, but now facing panel beating and insurance admin so meh), and the GF had some terrible reaction to something and ended up with a rash that developed into very painful blisters, so had her at the doc this morning to get drugged up etc.
Could have done without it all in all.
--A
Apart from my birthday, I also had some idiot drive into me, (nothing serious, just cosmetic damage, but now facing panel beating and insurance admin so meh), and the GF had some terrible reaction to something and ended up with a rash that developed into very painful blisters, so had her at the doc this morning to get drugged up etc.
Could have done without it all in all.
--A